Abstracts tagged "quality measures"

Abstract Number: 179 • 2020 Pediatric Rheumatology Symposium
New Juvenile Idiopathic Arthritis Quality Measure Set for the Pediatric Rheumatology Care and Outcomes Improvement Network
Julia Harris¹, Esi Morgan ², Sheetal Vora ³, Mileka Gilbert ⁴, Cagri Yildirim-Toruner ⁵, Nancy Griffin ⁶, Kerry Ferraro ⁷, Stephanie Loos ⁶, Tingting Qiu ⁶, Anne Paul ⁸, Jon Burnham ⁹, Erik Meyer ⁷, Michelle Batthish ¹⁰, Beth Gottlieb ¹¹, Danielle Bullock ¹², Melissa Hazen ¹³, Ronald Laxer ¹⁴, Tzielan Lee ¹⁵, Melissa Mannion ¹⁶, Judyann Olson ¹⁷, Michael Shishov ¹⁸, Richard Vehe ¹⁹, Jennifer Weiss ²⁰ and C. April Bingham ²¹, ¹Children's Mercy Kansas City, Overland Park, ²Cincinnati Children's Hospital, Cincinnati, ³Atrium Health Levine Children's Hospital, Charlotte, ⁴Medical University of South Carolina, Charleston, South Carolina, ⁵Nationwide Children's Hospital, Columbus, ⁶Cincinnati Children's Hospital Medical Center, Cincinnati, ⁷Pediatric Rheumatology Care and Outcomes Improvement Network, Cincinnati, ⁸Cincinnati Children's Hospital Medical Centre, Cincinnati, ⁹Children's Hospital of Philadelphia, Philadelphia, ¹⁰McMaster University, Hamilton, Canada, ¹¹Cohen Children's Medical Center, Lake Success, ¹²University of Minnesota, Minneapolis, ¹³Boston, ¹⁴The Hospital for Sick Children and University of Toronto, Toronto, Canada, ¹⁵Stanford Children's, Palo Alto, ¹⁶University of Alabama at Birmingham, Birmingham, ¹⁷Medical College of Wisconsin: Children's Wisconsin, Wauwatosa, Wisconsin, ¹⁸Phoenix Children's Hospital, Phoenix, ¹⁹University of Minnesota, Roseville, ²⁰Hackensack University Medical Center, Hackensack, ²¹Penn State Children's Hospital, Allentown
Background/Purpose: The Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) is a learning network to support pediatric rheumatology centers in improving care delivery and patient…
Abstract Number: 304 • 2019 ACR/ARP Annual Meeting
The ACR’s Rheumatology Informatics System for Effectiveness (RISE) Demonstrates Improvements in Many Measures of Quality of Care Between 2015 and 2017
Zara Izadi¹, Gabriela Schmajuk ², Julia Kay ³, Michael Evans ¹ and Jinoos Yazdany ³, ¹UCSF Division of Rheumatology, San Francisco, ²UCSF, SFVAMC Division of Rheumatology, San Francisco, CA, ³UCSF Division of Rheumatology, San Francisco, CA
Background/Purpose: The ACR’s Rheumatology Informatics System for Effectiveness (RISE) is an EHR‐enabled registry that represents over 36% of the U.S. clinical rheumatology workforce and calculates…
Abstract Number: 1252 • 2018 ACR/ARHP Annual Meeting
Screening for Tuberculosis before Initiating TNF Inhibitors: How Well Do We Do? a Nationwide Experience
Karim Ladak¹, Ting Pan² and Catherine MacLean¹, ¹Rheumatology, Hospital For Special Surgery, New York, NY, ²Value Office, Hospital For Special Surgery, New York, NY
Background/Purpose: Tumor necrosis factor inhibitors (TNFi) revolutionized treatment of various conditions, however they drastically increase the risk of latent tuberculosis (LTBI) reactivation. Many national medical…
Abstract Number: 1084 • 2017 ACR/ARHP Annual Meeting
Emdhaq: (electronic multidimensional health assessment questionnaire) to Record and Document eRAPID3 (electronic routine assessment of patient index data3) and eFAST3 (electronic fibromyalgia assessment screening tool3) in Routine Rheumatology Care
Theodore Pincus¹, Jacquelin R. Chua², Shakeel M. Jamal², Nathaniel Cook³, Niels Steen Krogh⁴, Anne-Marie Malfait¹ and Joel A. Block², ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Division of Rheumatology, Rush University Medical Center, Chicago, IL, ³Infectious Disease, Rush University Medical Center, Chicago, IL, ⁴ZiteLab ApS, Copenhagen, Denmark
Background/Purpose: RAPID3 (routine assessment of patient index data) on a multi-dimensional health assessment questionnaire (MDHAQ) distinguishes active from control treatments in RA clinical trials as…
Abstract Number: 1797 • 2017 ACR/ARHP Annual Meeting
Insights from Treating to Target in Rheumatoid Arthritis at an Academic Medical Center
Malithi Jayasundara¹, Ryan Jessee², Jason Weiner³, Tayseer Haroun⁴, Stephanie Giattino⁵, Atul Kapila⁴, Jenelle Hall⁴, Lisa Carnago⁴ and Lisa Criscione-Schreiber⁶, ¹Rheumatology, Duke University, Durham, NC, ²Department of Medicine, Division of Rheumatology and Immunology, Duke University, Durham, NC, ³Department of Medicine, Division of Rheumatology and Immunology, Duke University Medical Center, Durham, NC, ⁴Duke University, Durham, NC, ⁵Rheumatology, Duke University Medical Center, Durham, NC, ⁶Internal Medicine, Duke University Medical Center, Durham, NC
Background/Purpose: Current RA guidelines recommend treating to a target of remission or low disease activity (RM/LDA) state. In a prior quality improvement (QI) project, our…
Abstract Number: 2985 • 2016 ACR/ARHP Annual Meeting
Practice-Level Variation in Quality of Care in the Acr’s Rheumatology Informatics System for Effectiveness (RISE) Registry
Jinoos Yazdany¹, Nick Bansback², Megan E. B. Clowse³, Deborah Collier⁴, Karen Law⁵, Katherine Liao⁶, Kaleb Michaud⁷, Esi Morgan⁸, Jim Oates⁹, Catalina Orozco¹⁰, Andreas Reimold¹¹, Julia F Simard¹², Rachel Myslinski¹³, Tracy Johansson¹⁴ and Salahuddin Kazi¹⁵, ¹Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ²School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada, ³Rheumatology, Duke University School of Medicine, Durham, NC, ⁴Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁵Internal Medicine, Emory University School of Medicine, Atlanta, GA, ⁶Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, ⁷University of Nebraska Medical Center, Omaha, NE, ⁸Pediatric rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁹Medicine/Rheumatology & Immunology, Medical University of South Carolina, Charleston, SC, ¹⁰Rheumatology Associates, Dallas, TX, ¹¹Hospital of Southern Norway, Kristiansand, Norway, ¹²Division of Epidemiology, Health Research and Policy Department, and Division of Immunology & Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA, ¹³Governance & Ethics Specialist, Amer College of Rheumatology, Atlanta, GA, ¹⁴Practice, Advocacy & Quality, American College of Rheumatology, Atlanta, GA, ¹⁵Rheumatology, UT Southwestern Medical Center, Dallas, TX
Background/Purpose: The Medicare Access and CHIP Reauthorization Act (MACRA) of 2015 has put into place an aggressive timeline for a Merit-Based Incentive Payment System (MIPS)…
Abstract Number: 1998 • 2015 ACR/ARHP Annual Meeting
A National Electronic Health Record-Enabled Registry in Rheumatology: The ACR’s Rheumatology Informatics System for Effectiveness (RISE)
Jinoos Yazdany¹, Rachel Myslinski², Melissa Francisco³, Nick Bansback⁴, Megan E. B. Clowse⁵, Deborah Collier⁶, Karen Law⁷, Katherine Liao⁸, Kaleb Michaud⁹, Esi Morgan-DeWitt¹⁰, Jim Oates¹¹, Catalina Orozco¹², Andreas Reimold¹³, Julia F Simard¹⁴ and Salahuddin Kazi¹⁵, ¹University of California, San Francisco, San Francisco, CA, ²Governance & Ethics Specialist, Amer College of Rheumatology, Atlanta, GA, ³Practice, Advocacy & Quality, American College of Rheumatology, Atlanta, GA, ⁴Population and Public Health, The University of British Columbia, Vancouver, BC, Canada, ⁵Clinical Rheumatologist, Duke University Medical Center, Durham, NC, ⁶Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁷Emory University School of Medicine, Atlanta, GA, ⁸Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA, ⁹Rheumatology & Immunology, University of Nebraska Medical Center and National Data Bank, Omaha, NE, ¹⁰Pediatric rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ¹¹Medicine, Medical University of South Carolina, Charleston, SC, ¹²Arthritis Consultation Ctr, Dallas, TX, ¹³Rheumatology, VAMC, University of Texas Southwestern Medical Center, Dallas, TX, ¹⁴Division of Epidemiology, Health Research and Policy Department, and Division of Immunology & Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA, ¹⁵Internal Medicine/Rheumatology, UT Southwestern Medical Center, Dallas, TX
Title: A National Electronic Health Record-Enabled Registry in Rheumatology: The ACR's Rheumatology Informatics System for Effectiveness (RISE)Background/Purpose: In 2014, the ACR launched the Rheumatology Informatics…
Abstract Number: 1834 • 2014 ACR/ARHP Annual Meeting
Uptake of the American College of Rheumatology’s (ACR) Rheumatology Clinical Registry (RCR): Quality Measure Summary Data
Natalie Fisk¹, Melissa Francisco², Jinoos Yazdany³ and Salahuddin Kazi⁴, ¹Registry, American College of Rheumatology, Atlanta, GA, ²American College of Rheumatology, Atlanta, GA, ³Medicine, University of California, San Francisco, San Francisco, CA, ⁴Internal Medicine/Rheumatology, UT Southwestern Medical Center, Dallas, TX
Background/Purpose: The RCR is designed to provide ACR members with an infrastructure for quality reporting related to rheumatoid arthritis, gout, osteoarthritis, osteoporosis, and drug safety.…
Abstract Number: 1351 • 2014 ACR/ARHP Annual Meeting
Assessment of ACR Endorsed Quality Indicators in Rheumatoid Arthritis Patients – a Quality Improvement Initiative
Puneet Bajaj¹, Erik Anderson², Siddharth Raghavan², Asha Patnaik¹ and Heidi Roppelt¹, ¹Rheumatology, Stony Brook University Medical Center, East Setauket, NY, ²Internal Medicine, Stony Brook University Medical Center, East Setauket, NY
Background/Purpose: Quality assessments are being increasingly used for quality improvement, accountability, and performance based incentives. The current research regarding quality of care provided to rheumatoid…
Abstract Number: 899 • 2014 ACR/ARHP Annual Meeting
Insurance Status and U.S. Region Associated with Placement of Permanent Vascular Access in Dialysis Patients with End-Stage Renal Disease Secondary to Lupus Nephritis
Laura Plantinga¹, Cristina M. Drenkard², Rachel Patzer³, William McClellan¹, Stephen Pastan⁴ and S. Sam Lim⁵, ¹Department of Epidemiology, Emory University, Atlanta, GA, ²Medicine, Div Rheumatology, Emory University, Atlanta, GA, ³Department of Surgery, Emory University, Atlanta, GA, ⁴Department of Medicine, Division of Renal Medicine, Emory University, Atlanta, GA, ⁵Emory University School of Medicine, Division of Rheumatology, Atlanta, GA
Background/Purpose: Prior data suggest sociodemographic and regional variability in various indicators of quality of end-stage renal disease (ESRD) care, both overall and in the SLE…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].